ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 333

Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort

christian roux1, joel Coste2, Bernard Mazieres3, Coralie Roger4, eric Fontas5, Bruno fautrel6, Jacques Pouchot7,8, Patrice Fardellone9,10, Anne-Christine Rat11,12, alain Saraux13, Francis Guillemin14 and Liana Euller Ziegler15, 1Rheumatology, LAMHESS laboratory, sofia antipolis university, CHU Pasteur 2, Nice, France, nice, France, 2Biostatistique, Unité INSERM 875, Hotel Dieu, Paris, france, Paris, France, 3Rheumatology department, Hospital Toulouse, france, toulouse, France, 4Direction recherche clinique, Hopital universitaire de Nice, nice, France, 5Direction recherche clinique, CHU de Nice, france, Nice, France, 6rheumatology department, Hospital Pitié Salpétrière, Paris, france, Paris, France, 7internal medicine, Hôpital Européen Georges Pompidou, AP-HP, Paris, France, 8Paris University, Internal medicine, Paris, France, 9Rheumatology, Hopital Nord Amiens, Amiens, France, 10Department of Rheumatology, Amiens University hospital, Amiens, France, 11CHU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, 12Service de Rhumatologie, Nancy-University, Paris Descartes, Metz P Verlaine, EA 4003; Department of clinical epidemiology and evaluation, Nancy University Hospital; Department of rheumatology, Nancy University Hospital, Vandoeuvre les Nancy, France, 13Rheumatology Department, CHU la cavale Blanche, brest, france, Brest, France, 14Department of Clinical Epidemiology and Evaluation, Nancy University Hospital, Nancy-University, EA 4003, Nancy, France, 15151 rte de St Antoine de Gines, CHU de Nice -Université Nice Sophia Antipolis, Nice, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Hip, Knee, Osteoarthritis and radiology

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Relations between smoking and osteoarthritis remains discussed. The protective effect found in previous epidemiological studies has not been confirmed by recent studies and meta analyses. This study aims to investigate the effect of smoking on pain, function and structural evolution in hip and knee symptomatic osteoarthritis.

Methods:

The subjects studied were enrolled in the KHOALA cohort (Knee and Hip OsteoArthritis Long-term Assessment) which has been described in detail elsewhere. Briefly, it is a population-based cohort of 878 subjects aged from 40 to 75 years with symptomatic lower limb OA (knee and/or hip).  Data were collected at baseline and after three years during an outpatient visit, and each year with self-administered questionnaires. The data collected included demographic characteristics, and annual data for pain (0-100), function (Harris Hip Score and Womac), smoking information (duration, amount and ongoing). Standard radiographs of both hips were obtained at baseline and at three years. The progression of hip and or knee osteoarthritis was evaluated according to the radiological Kellgren-Lawrence score (KL), osteophytes scores (0-3) per location and swelling. Univariate and multivariate statistical analysis were performed adjusted on age, BMI, sex and diabetes. the subjects were divided into smokers, non-smokers and former smokers.

Results:

873 subjects have been included, 119 smokers, 215 former smokers et 539 non-smokers, 64% of smokers and 31 % of former smokers have smoked during over 20 years. 40% of smokers have smoked 20 pack years. 20 subjects were not taken into account due to lack of data. Baseline characteristics are presented in table with comparisons between baseline and 3 years

At 3 years, no difference has been shown between different groups about function, pain and structural evolution for the hip (0.16) and knee (p=0.9) as for the laying prosthesis (p=0.4 and p=0.5). But smokers (OR=0.33 [0.11-1.09]) and former smokers (OR=0.30[0.1-0.85]) developed fewer osteophytes only in the knee either in medial and lateral condyles (p=0.037 and 0.07). The dose of intoxication (p = 0.026 (OR = 0.98 [0.97-1]) and the duration of intoxication (p = 0.0005 (OR = 0.98 [0.97-0.99]) were significantly associated with the development of these osteophytes. No difference is found for other structural parameters.

Conclusion:

Our results shows that smoking does not influence function and pain but smokers and ancient smokers seems to develop less osteophytesat femoral level. As a possible explanation, recent experimental studies have shown that nicotine upregulated collagen synthesis, chondrocytes proliferation and influences TGFβ synthesis which is involved in the formation of osteophytes.these results needs to be confirmed.

 

Smokers

Baseline

former smokers

Baseline

Non mokers

Baseline

P*

P**

P***

Age                                       mean (SD)

57 (9)

62 (8)

63 (8)

0.0001

 

 

BMI                                       mean (SD)

28.2 (6)

29.1 (6)

29.8 (6)

0.009

 

 

Knee Pain (0-100)                median

30

25

35

0.01

NS

NS

Knee Function  (womac)       median

28.1

25

31.3

0.03

NS

NS

Smoking dose (pack-year)     mean (SD)

21 (16)

16 (15)

 

 

 

 

Smoking duration (years)       mean (SD)

29 (13)

19 (12)

 

 

 

 

Knee OA   KL≥2                       n (%)

79 (94)

148 (92.5)

376 (82.2)

NS

NS

NS

Knee Osteophytes MC           n(%)

45 (53.6)

87 (54.4)

239 (58.6)

NS

0.03

0.04

Knee osteophytes LC              n (%)

17 (20.2)

42 (26.3)

129 (31.6)

0.04

0.05

0.06

Knee osteophytes MP            n (%)

29 (35)

64 (40)

169 (41)

0.4

NS

NS

Knee osteophytes LP            n (%)

52 (62)

95 (59)

245 (60)

0.9

NS

NS

Hip OA   KL≥2                       n (%)   

(38.5)

(27.9)

(29)

0.01

NS

NS

Hip function (Harris)           median

84

78.9

80

NS

NS

NS


Disclosure: C. roux, None; J. Coste, None; B. Mazieres, None; C. Roger, None; E. Fontas, None; B. fautrel, None; J. Pouchot, None; P. Fardellone, None; A. C. Rat, None; A. Saraux, None; F. Guillemin, None; L. Euller Ziegler, None.

To cite this abstract in AMA style:

roux C, Coste J, Mazieres B, Roger C, Fontas E, fautrel B, Pouchot J, Fardellone P, Rat AC, Saraux A, Guillemin F, Euller Ziegler L. Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/smoking-and-knee-and-hip-osteoarthritis-evolution-results-from-the-knee-and-hip-osteoarthritis-long-terme-assessment-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smoking-and-knee-and-hip-osteoarthritis-evolution-results-from-the-knee-and-hip-osteoarthritis-long-terme-assessment-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology